Risperidone-associated galactorrhea in a male teenager [4]

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 40, Issue 5, 2001, Pages 504-505

  Gupta, S ^a   Frank, B ^a   Madhusoodanan, S ^a  

^a Olean General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN;

ADOLESCENT; CASE REPORT; DEPRESSION; DOPAMINERGIC NERVE CELL; DRUG INDUCED DISEASE; DRUG MECHANISM; GALACTORRHEA; HALLUCINATION; HUMAN; LETTER; MALE; MANIA; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SUICIDAL BEHAVIOR;

EID: 0035029352     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200105000-00006     Document Type: Letter

References (8)

1. ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo controlled trial in patients with schizophrenia
2. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia
3. Risk factors for secondary amenorrhea and galactorrhea
4. Case Study: Risperidone treatment of children and adolescents with developmental disorders
5. Risperidone in the treatment of schizophrenia
6. Effect of clozapine on human serum prolactin levels
7. Risperidone induced galactorrhea associated with prolactin elevation
8. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophrenic disorders: Results of an international collaborative trial